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Abstract
Background: T1 mapping is emerging as a powerful tool in cardiac magnetic resonance (CMR) to evaluate diffuse
fibrosis. However, right ventricular (RV) T1 mapping proves difficult due to the limited wall thickness in diastolic phase.
Several studies focused on systolic T1 mapping, albeit only on the left ventricle (LV).
Purpose: To estimate intra- and inter-observer variability of native T1 (nT1) mapping of the RV, and its correlations
with biventricular and pulmonary function in patients with congenital heart disease (CHD).
Material and Methods: In this retrospective, observational, cross-sectional study we evaluated 36 patients with CHD,
having undergone CMR on a 1.5-T scanner. LV and RV functional evaluations were performed. A native modified look-
locker inversion recovery short-axis sequence was acquired in the systolic phase. Intra- and inter-reader
reproducibility were reported as complement to 100% of the ratio between coefficient of reproducibility and mean.
Spearman q and Mann–Whitney U-test were used to compare distributions.
Results: Intra- and inter-reader reproducibility was 84% and 82%, respectively. Median nT1 was 1022ms (interquartile
range [IQR] 1108–972) for the RV and 947ms (IQR 986–914) for the LV. Median RV–nT1 was 1016ms (IQR 1090–1016)
in patients with EDVI 100mL/m2 and 1100ms (IQR 1113–1100) in patients with EDVI >100mL/m2 (P¼ 0.049).
A significant negative correlation was found between RV ejection fraction and RV–nT1 (q¼0.284, P¼ 0.046).
Conclusion: Systolic RV-nT1 showed a high reproducibility and a negative correlation with RV ejection fraction,
potentially reflecting an adaptation of the RV myocardium to pulmonary valve/conduit (dys)-function.
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Introduction
The use of T1 mapping in cardiac magnetic resonance
(CMR) to evaluate diffuse fibrosis of the left ventricle
(LV) is emerging as a powerful tool in the diagnosis of
LV cardiomyopathies (1). T1 mapping provides para-
metric maps representing T1 values in milliseconds on
a voxel-by-voxel basis. Native T1 (nT1) reflects the com-
position of both the intra- and extra-cellular compart-
ment (2). Normal myocardial nT1 values at 1.5 T using
modified look-locker inversion recovery (MOLLI)
sequence are reported to be in the range of
895–1035ms (3). Increased or decreased T1 values com-
pared to this normal range were observed in several
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myocardial diseases, showing a potential of T1 mapping
as a tool for clinical diagnosis (4).
In patients with congenital heart disease (CHD),
CMR is a non-invasive imaging modality, highly reli-
able for studying heart morphology and function (5).
Diagnoses and treatment planning may be based on
CMR, in particular as far as the assessment of right
ventricle (RV) volumes and function is concerned (6).
Notably, a strong correlation can be demonstrated
between late gadolinium enhancement (LGE) and his-
tology in CHD patients (7,8). However, the role of T1
mapping in diffuse myocardial changes is still under
investigation, as nT1 could be an important early indi-
cator of cardiac dysfunction.
Kozak et al. (9) demonstrated alterations of LV and
RV T1 mapping in patients with tetralogy of Fallot
(ToF) using a T1 mapping sequence at the end-
diastolic phase. However clinical experience suggests
this approach has the limitation of such patients
having a very thin RV wall, implying substantial diffi-
culties in positioning regions of interest (ROIs) within
the myocardial wall. This may also be inferred from the
SDs of RV T1 times of Kozak et al. (9), which are 10
points higher than their LV counterparts. The same lim-
itation was cited in a study published by Jellis et al. (10),
that correlated RV T1 mapping with RV dysfunction in
patients with non-ischemic cardiomyopathies. To over-
come this limit, Kawel-Boehm et al. (11) tried to per-
form RV T1 mapping with a T1 mapping sequence
applied at end-systolic phase. However, this sequence
was only tested in healthy volunteers.
Several experiences regarding the systolic approach
of T1 mapping are present in the literature (12–15).
However, all these studies only focused on the LV.
The aim of the present study was to appraise intra-
and inter-observer variability of nT1 mapping of the
RV at systolic phase, and to analyze potential correla-
tions between nT1 mapping of the RV and LV and
functional parameters and pulmonary regurgitation in
patients with CHD.
Material and Methods
Study population
The local Ethics Committee approved this study
(Ethics Committee of San Raffaele University
Hospital; protocol code CardioRetro; approved on
9 March 2017). This study was partially supported
by Ricerca Corrente funding from Italian Ministry
of Health to IRCCS Policlinico San Donato. This
research received no specific grant from any funding
agency in the public, commercial, or not-for-profit
sectors. Due to the retrospective nature of the
present study, no specific informed consent was nec-
essary .
We retrospectively evaluated 36 patients who under-
went CMR at our institution between March 2015 and
March 2017.
CMR protocol
Examinations were performed using a 1.5-T scanner
(Magnetom Aera, Siemens Healthcare) with 45mT/m
gradient power, using an 18-channel surface phased-
array coil placed over the thorax and with the patient
in supine position.
Examinations were conducted according to standard
clinical practice for patients with CHD. For each
patient, LV and RV functional evaluation was per-
formed. Every CMR study included a complete set of
short-axis (from base to apex) cine images, using an
electrocardiographically triggered steady-state free pre-
cession pulse sequence acquired with the following tech-
nical parameters: time of repetition (TR)/time of echo
(TE)¼ 4.0/1.5ms; flip angle¼ 80; slice thickness¼
8mm; time resolution¼ 45ms; mean acquisition time¼
14 4 s (mean SD); number of phases¼ 30; and
in-plane pixel size¼ 1.40 1.80mm2.
Pulmonary flow analysis was performed with phase-
contrast (PC) sequences and regurgitation fraction
(RF) was calculated. PC through-plane sequences
were used for blood flow quantification. Images per-
pendicular to the main pulmonary artery were acquired
at about 1 cm distal from pulmonary valve. A breath-
hold spoiled gradient echo sequence (fast low-angle
shot) was performed for phase-velocity mapping
with the following technical parameters: TR/TE¼
37.12/2.47ms; slice thickness¼ 5mm; velocity encoding
(VENC)¼ 150–350 cm/s; time resolution¼ 41ms; mean
acquisition time¼ 15 4 s; and in-plane pixel size¼
1.40 1.40mm2. Initially, we acquired the PC sequence
with a VENC of 150 cm/s. In the presence of aliasing, we
modified the VENC adding 50 cm/s for each new
sequence.
A native MOLLI sequence with 5(3)3 protocol was
acquired at the basal, ventricular level in short-axis
view in systole, by starting the data acquisition at an
individually adapted trigger time. The MOLLI
sequence included motion correction and subsequent
automatic generation of T1 maps. MOLLI sequences
were acquired with the following parameters: TE/
TR¼ 1.12/2.8ms; flip angle¼ 35; bandwidth¼ 1085
Hz/pixel; in-plane pixel size¼ 1.40 1.80mm2; and
parallel imaging factor¼ 2.
LGE sequences were acquired after intravenous
administration of 0.10mmol/kg of gadobutrol
(Gadovist, Bayer Healthcare, Leverkusen, Germany)
and were performed using a two-dimensional (2D)
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inversion-recovery fast gradient-echo sequence. The
echo time was 3.33ms, while the repetition time was
adapted to patients’ heart rates, and inversion time
was progressively modified from 260ms to 330ms, to
blacken cardiac muscle; the flip angle was 25, slice
thickness was 8mm, and pixel size was 3.6mm2.
Image assessment
A radiologist with 10 years of experience with CMR
performed the segmentation of cardiac and flow images
using MEDIS QMass 7.6 and QFlow 5.6 (Medis
Medical Imaging Systems).
For the segmentation of cardiac images, the reader
manually traced epicardial contour at both the
end-diastolic and end-systolic phases. Then, a blood
thresholding technique (Mass-K mode) was applied,
and end-diastolic volume index with regards to body
surface area (EDVI), end-systolic volume (ESVI),
stroke volume (SV), and ejection fraction (EF) were
calculated automatically. A 50% threshold was fixed
using Mass-K mode (16).
For the segmentation of pulmonary flow, the reader
selected the vessel boundary of a slice and prompted
the software to propagate the segmentation through
the remaining slices. The software performed an auto-
mated adjustment, and the reader could manually cor-
rect the adjusted contours. Forward flow, backward
flow, and peak velocity were obtained (17).
To measure nT1 time of the RV and LV myocardi-
um, a ROI was drawn on the end-systolic T1 maps
using a freehand ROI tool. Such a ROI was drawn in
each patient on the inferior wall of the basal slice to
avoid blood contamination as much as possible.
In order not to place the ROI in a scarred area with
fibrotic tissue, LGE images were used as a reference for
localization. The most appropriate imaging plane for
measuring T1 time of the RV myocardium was deter-
mined by the ability to draw a ROI on the correspond-
ing T1 map being sure not to include any adjacent
blood or non-myocardial tissue only in diaphragmatic
wall from short-axis views. nT1 time of the RV and LV
myocardium were measured on the T1 map in the most
appropriate imaging plane at end systolic phase.
All measurements were performed on color-coded T1
maps as shown in Fig. 1. The window setting was indi-
vidually adjusted for each T1 map, aiming not to gen-
erate homogeneously colored myocardium that could
hide partial-volume effects by inclusion of adjacent
blood or non-myocardial tissue. ROIs were positioned
in the inferior wall of the RV, where no fibrosis was
expected. To assess inter- and intra-reader reproduc-
ibility, a second reader, i.e. a radiology resident with
one year of experience in CMR reperformed two addi-
tional sets of measurements of nT1 independently.
Statistical analysis
Bland–Altman method was used to estimate the intra-
and inter-reader reproducibility on measurements from
the basal slice. The intra-reader reproducibility was
performed only for the second reader, with at least a
10-day interval between the two sessions. The coeffi-
cient of repeatability (CoR) was calculated as
1.96 SD of the differences of the two datasets.
Variability was reported as bias, CoR, and reproduc-
ibility (R) as complement to 100% of the ratio between
CoR and bias, along with Bland–Altman plots.
Correlation coefficients were classified according to
Cohen (18).
Parametric variables were expressed as meanSD,
whereas non-parametric variables were expressed as
median (interquartile ranges [IQR]). Spearman’s rho
was used to correlate the nT1 of RV and LV to func-
tional parameters. The Mann–Whitney U-test was used
to compare nT1 of RV and LV in groups of patients
with different RV-EDVI. According to Maceira et al.
(19), 100mL/m2 of EDVI was considered the cut-off
for RV dilation.
Results
Study population and functional parameters
Our study population consisted of 36 patients (10
women; mean age¼ 25 12 years). They represented a
wide spectrum of diseases as summarized in Table 1.
Functional parameters are shown in Table 2. RV nT1
was 1022ms (IQR¼ 968 1108ms) at the base, 962ms
(IQR¼ 894 1014ms) at mid-level, and 956ms
(IQR¼ 915–1028ms) at the apex. Moderate, positive
correlations were present among nT1 values between
the base and mid-level (q¼ 0.501, P¼ 0.002), base and
apex (q¼ 0.511, P¼ 0.001), and a strong, positive
Fig. 1. Example of automatic generation of T1 maps short-axis
modified look-locker inversion recovery (MOLLI) sequence at
end-systolic phase. A region of interest is drawn in the basal
diaphragmatic wall of the right ventricle.
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correlation was observed mid-level and apex (q¼ 0.777,
P< 0.001).
Intra- and inter-reader reproducibility
Intra-reader variability analysis showed a bias of
6.81ms and a CoR of 170ms, thus a R of 84%,
while inter-reader variability showed a bias of
3.24ms, a CoR of 164ms, and a R of 82%.
Correlations
A weak negative correlation was found between RVEF
and RV nT1 (q¼ –0.284, P¼ 0.046) (Fig. 2). Regarding
the LV, a moderate positive correlation was found
between LVESVI and LV nT1 (q¼ 0.396, P¼ 0.012)
(Fig. 3) and a weak borderline positive correlation
was found between LVEDVI and LV nT1 (q¼ 0.287,
P ¼ 0.056). A moderate negative correlation was found
between LVEF and LV nT1 (q¼ –0.337, P¼ 0.029)
(Fig. 4). A weak borderline positive correlation was
found between nT1 RV and nT1 LV (q¼ 0.272,
P¼ 0.066). No other significant correlations were
found (Table 3). Median RV nT1 was 1016ms
(IQR¼ 1016–1090ms) in patients with non-
pathological EDVI (100mL/m2) and 1100ms
(IQR¼ 1100–1113ms) in patients with pathological
EDVI (>100mL/m2), with a significant difference
(P¼ 0.049).
Discussion
In the present study, RV nT1 values were assessed in
patients with CHD. Systolic quantification of T1 values
of the RV showed a good inter- and intra-reader var-
iability, as CoR was not too large when compared to
the obtained T1 values. Another important result was
the detection of a significant negative correlation
between RVEF and nT1 with a good reproducibility
of our measurements.
Our CHD population was characterized by normal
LV function and volume, and a relative increase of
RVEDVI, reflecting a dysfunction of the pulmonary
valve/conduit. As is well-known, the timing of surgi-
cal/percutaneous procedure in these patients depends
on clinical conditions, RV volumes, and degree of pul-
monary valve dysfunction (20). However, in some
cases, the remodeling of the RV is faster than expected,
and the procedure is performed too late to observe a
reversion of such remodeling. The possibility of mea-
suring nT1, which reflects a fibrotic alteration of RV
wall, may be used to distinguish those patients who
may encounter a faster deterioration of RV volumes,
and need earlier intervention.
The negative correlation between nT1 and RVEF
may point that patients with an impaired RV function
had an increase of mobile water species and/or intersti-
tial deposition of collagen in the RV diaphragmatic
wall. This abnormality could be correlated with RV
Table 1. Demographics, spectrum of diseases, and cardiac
functional parameters.
Patients
Patients (n) 36
Age (years) 25 12
Women 10 (27)
Men 26 (73)
Congenital heart disease
Tetralogy of Fallot 25 (69)
Aortic valve stenosis (Ross) 5 (15)
Pulmonary valve atresia 3 (8)
Pulmonary valve stenosis 3 (8)
Values are given as n (%) or mean SD.
Table 2. Functional parameters.
Parameters
Left ventricle
End-diastolic volume index (mL/m2) 70 (63–78)
End-systolic volume index (mL/m2) 24 (21–28)
Stroke volume (mL) 80 (66–89)
Ejection fraction (%) 64 (60–66)
Left ventricle native T1 (ms) 947 (914–986)
Right ventricle
End-diastolic volume index (mL/m2) 90 (72–117)
End-systolic volume index (mL/m2) 40 (30–55)
Stroke volume (mL) 85 (69–106)
Ejection fraction (%) 54 (50–62)
Regurgitation fraction (%) 27 (8–41)
Pulmonary peak velocity (m/s) 3.2 (2.5–3.4)
Right ventricle native T1 (ms) 1022 (972–1108)
Values are given as median (interquartile range).
Fig. 2. Correlation between RVEF and RV nT1 (q¼ –0.284, P ¼
0.046). RVEF, right ventricle ejection fraction; RV nT1, right
ventricle native T1.
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dilation and dysfunction. The existence of a positive
correlation between nT1 RV and nT1 LV may be
found in an increase in nT1 RV due to RV dysfunction
which can be associated with a minor alteration of LV
myocardium, even when LV function is preserved.
Other interesting correlations were found between
LV nT1 and LV volumes as well as between LV nT1
and LVEF. An increase in LVEDVI and LVESVI and
a decrease in LVEF correlated with an increase in LV
nT1. These findings can be interpreted as an initial
Fig. 3. Correlation between left ventricle end systolic volume (LVESVI) and left ventricle native T1 (LV nT1) (q¼ 0.396, P ¼ 0.012).
Fig. 4. Correlation between LVEF and LV nT1 (q¼ –0.337 P ¼ 0.029). LVEF, left ventricle ejection fraction; LV nT1, left ventricle
native T1.
Table 3. Correlations between functional parameters of right ventricle and left ventricle, pulmonary valve function and native T1
mapping of right and left ventricles.
RVEDVI RVESVI RVSV RVEF LVEDVI LVESVI LVSV LVEF pRF pPG LV nT1
RV nT1 q¼ –0.038
P ¼ 0.413
q¼ 0.134
P ¼ 0.218
q¼ –0.245
P ¼ 0.075
q5 –0.284
P 5 0.046
q¼ 0.036
P ¼ 0.417
q¼ 0.055
P ¼ 0.375
q¼ 0.029
P ¼ 0.434
q¼ –0.173
P ¼ 0.156
q¼ –0.210
P ¼ 0.109
q¼ –0.073
P ¼ 0.336
q5 0.272
P 5 0.066
LV nT1 q¼ 0.251
P ¼ 0.830
q¼ 0.200
P ¼ 0.136
q¼ 0.013
P ¼ 0.471
q¼ –0.120
P ¼ 0.257
q5 0.287
P 5 0.056
q5 0.396
P 5 0.012
q¼ –0.064
P ¼ 0.364
q5 –0.337
P 5 0.029
q¼ –0.072
P ¼ 0.348
q¼ 0.227
P ¼ 0.106
The values in bold indicate statistical significance.
LVEDVI, left ventricle end-diastolic volume index; LVEF, left ventricle ejection fraction; LVESVI, left ventricle end-systolic volume index; LV nT1, native
T1 mapping left ventricle; LVSV, left ventricle stroke volume; pPG, pulmonary pressure gradient; pRF, pulmonary regurgitant fraction; RVEDVI, right
ventricle end-diastolic volume index; RVEF, right ventricle ejection fraction; RVESVI, right ventricle end-systolic volume index; RV nT1, native T1
mapping of right ventricle; RVSV, right ventricle stroke volume.
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adaptation of LV to the modifications of RV due to the
LV volume overload.
Kozak et al. (9) published a similar study regarding
nT1 in patients with CHD. They found an alteration of
LV and RV nT1 in patients with ToF. However, in the
present study a T1 mapping sequence at end-diastolic
phase was used, implying substantial difficulties in
positioning ROIs within a very thin RV wall.
Conversely, our approach of a T1 mapping sequence
acquired at end-systolic phase limited this problem.
The present study has some limitations. The first is
the possibility of blood contamination of nT1 measure-
ments in the inferior wall due to the hyper-
trabeculation of the RV which could potentially be
supported by the fact that RV nT1 is higher than LV
nT1, and the negative correlation between RVEF and
RV nT1. Moreover, a larger RV volume will also mean
that the wall is thinner and thus more prone to signal
from blood into the RV ROI. Further studies on large,
heterogeneous samples might be needed to verify
whether this may stem from a systematic error due to
blood contamination, or if nT1 is indeed different and
thus blood contamination might be present, albeit with
a non-systematic pattern. Second, we did not estimate
extracellular volume fraction after intravenous admin-
istration of a gadolinium-based contrast material, while
it may be an accurate biomarker for diffuse myocardial
fibrosis in many cardiac diseases (21); however, con-
trast material injection was not included in the clinical
protocol of the majority of these patients, preventing
the obtaining of extracellular volume estimation.
Finally, the sample size was relatively small, although
measurements appear robust because a good reproduc-
ibility was obtained in spite of this limitation.
In conclusion, systolic nT1 mapping of the RV
showed satisfactory reproducibility, and nT1 values
obtained from mapping in systolic phase were higher
in presence of lower function, potentially reflecting an
adaptation of RV muscle following pulmonary valve/
conduit dysfunction. This finding, however, warrants
further studies on larger, heterogeneous samples for
confirmation. A possible application for this new
approach of end-systolic T1 mapping acquisition for
RV should be the evaluation of RV nT1 in patients
with pulmonary hypertension or in patients with RV
failure. Due to the limits of nT1 to clearly distinguish
interstitial from myocyte signal intensity, prospective
studies regarding RV extracellular volume in patients
with CHD are warranted.
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